Hidden brain atrophy in ultra-high-field MR images in a transgenic rat model of Huntington's disease

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Brain Disorders

• Publication date

  2022-05-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.dscb.2022.100039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• qMRLab: Quantitative MRI analysis, under one umbrella

  2020cited by this paper
• Mono-Exponential Fitting in T2-Relaxometry: Relevance of Offset and First Echo

  2015cited by this paper
• Altered diffusion tensor imaging measurements in aged transgenic Huntington disease rats

  2012cited by this paper
• Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease

  2012cited by this paper
• Microstructural changes observed with DKI in a transgenic Huntington rat model: Evidence for abnormal neurodevelopment

  2012cited by this paper
• Lessons Learned from the Transgenic Huntington's Disease Rats

  2012cited by this paper
• Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.

  2011cited by this paper
• Genotype specific age related changes in a transgenic rat model of Huntington's disease

  2011cited by this paper
• Advances in the Pharmacological Management of Huntington’s Disease

  2010cited by this paper
• Early atrophy of pallidum and accumbens nucleus in Huntington’s disease

  2010cited by this paper
• Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical "disconnection"

  2010cited by this paper
• Principles, techniques, and applications of T2*-based MR imaging and its special applications.

  2009cited by this paper
• Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

  2008cited by this paper
• Neurons in the fusiform gyrus are fewer and smaller in autism.

  2008cited by this paper
• Congenital hydrocephalus associated with abnormal subcommissural organ in mice lacking huntingtin in Wnt1 cell lineages.

  2008cited by this paper
• Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males.

  2008cited by this paper
• Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease.

  2007cited by this paper
• Cellular and subcellular localization of Huntington aggregates in the brain of a rat transgenic for Huntington disease

  2007cited by this paper
• User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability

  2006cited by this paper
• Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic ratmodel.

  2006cited by this paper
• The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.

  2006cited by this paper
• Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease.

  2006cited by this paper
• Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats.

  2006cited by this paper
• Acute and separate modulation of motor and cognitive performance in parkinsonian rats by bilateral stimulation of the subthalamic nucleus.

  2005cited by this paper
• Experimental therapeutics in transgenic mouse models of Huntington's disease

  2004cited by this paper
• Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease

  2004cited by this paper
• Evidence for progression in frontal cortical pathology in late‐stage Huntington's disease

  2004cited by this paper
• Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

  2004cited by this paper
• Novel aspects of the chemical anatomy of the striatum and its efferents projections.

  2003cited by this paper
• Transgenic rat model of Huntington's disease.

  2003cited by this paper
• Regional and progressive thinning of the cortical ribbon in Huntington’s disease

  2002cited by this paper
• Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells.

  2002cited by this paper
• The selective vulnerability of nerve cells in Huntington's disease

  2001cited by this paper
• Neuron loss during early adulthood following prenatal low-dose X-irradiation in the mouse brain.

  2001cited by this paper
• Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach.

  2000cited by this paper
• Delaying the onset of Huntington's in mice

  2000cited by this paper
• Wild-Type Huntingtin Protects from Apoptosis Upstream of Caspase-3

  2000cited by this paper
• Perinatal asphyxia results in changes in presynaptic bouton number in striatum and cerebral cortex-a stereological and behavioral analysis.

  2000cited by this paper
• Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization

  1999cited by this paper
• Recent Insights into the Molecular Pathogenesis of Huntington Disease

  1999cited by this paper
• Neuron loss in the mouse hippocampus following prenatal injection of tritiated thymidine or saline

  1999cited by this paper
• Caspase-8 is required for cell death induced by expanded polyglutamine repeats.

  1999cited by this paper
• Replicating Huntington's disease phenotype in experimental animals.

  1999cited by this paper
• Nerve cell loss in the thalamic mediodorsal nucleus in Huntington’s disease. II. Optimization of a stereological estimation procedure

  1999cited by this paper
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998cited by this paper
• Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

  1997cited by this paper
• Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

  1996cited by this paper
• Widespread expression of Huntington's disease gene (IT15) protein product.

  1995cited by this paper
• Trinucleotide repeat length instability and age of onset in Huntington's disease

  1993cited by this paper
• Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat.

  1993cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

  1991cited by this paper
• Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease

  1988cited by this paper
• Differential loss of striatal projection neurons in Huntington disease.

  1988cited by this paper
• RARE imaging: A fast imaging method for clinical MR

  1986cited by this paper
• Neuropathological Classification of Huntington's Disease

  1985cited by this paper
• Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics

  1972cited by this paper
• Edinburgh Research Explorer Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism

  year unknowncited by this paper

• The Anatomic Variability of the Lateral Ventricles of the Human Brain Depending on Age and Sex

  2023cites this paper